- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Intercept Pharmaceuticals (NASDAQ:ICPT), Quotes and News Summary
Intercept Pharmaceuticals (NASDAQ: ICPT)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-07-28 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.580 | 0.3200 | ||||
| REV | 90.490M | 88.582M | -1.908M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Intercept Pharmaceuticals Questions & Answers
You can purchase shares of Intercept Pharmaceuticals (NASDAQ: ICPT) through any online brokerage.
Other companies in Intercept Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Centessa Pharmaceuticals (NASDAQ:CNTA), Inovio Pharmaceuticals (NASDAQ:INO), Tango Therapeutics (NASDAQ:TNGX) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Intercept Pharmaceuticals (NASDAQ: ICPT) was reported by RBC Capital on Monday, May 9, 2022. The analyst firm set a price target for 18.00 expecting ICPT to rise to within 12 months (a possible 30.06% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Intercept Pharmaceuticals (NASDAQ: ICPT) is $13.84 last updated Today at July 1, 2022, 3:47 PM UTC.
There are no upcoming dividends for Intercept Pharmaceuticals.
Intercept Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Intercept Pharmaceuticals.
Intercept Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.